784
Participants
Start Date
June 30, 2005
Primary Completion Date
May 31, 2009
Study Completion Date
May 31, 2009
Tranexamic acid tablets (XP12B)
Two 650 mg tranexamic acid tablets (XP12B) taken 3 times daily (3900 mg/Day) for a maximum of 5 days during monthly menstruation
Investigative Site, Johnson City
Investigative Site, Wexford
Investigative Site, Philadelphia
Investigative Site, Norfolk
Investigative Site, Winston-Salem
Investigative Site, Durham
Investigative Site, Charlotte
Investigative Site, Columbia
Investigative Site, Alpharetta
Investigative Site, Roswell
Investigative Site, Savannah
Investigative Site, Savannah
Investigative Site, Miami
Investigative Site, West Palm Beach
Investigative Site, West Palm Beach
Investigative Site, Pinellas Park
Investigative Site, Fort Myers
Investigative Site, Venice
Investigative Site, Ocala
Investigative Site, New Port Richey
Investigative Site, Birmingham
Investigative Site, Montgomery
Investigative Site, Mobile
Investigative Site, Nashville
Investigative Site, Nashville
Investigative Site, Louisville
Investigative Site, Lexington
Investigative Site, Toledo
Investigative Site, Cincinnati
Investigative Site, Cincinnati
Investigative Site, Indianapolis
Investigative Site, South Bend
Investigative Site, Evansville
Investigative Site, Portage
Investigative Site, Chaska
Investigative Site, Billings
Investigative Site, Champaign
Investigative Site, St Louis
Investigative Site, St Louis
Investigative Site, St Louis
Investigative Site, Overland Park
Investigative Site, Omaha
Investigative Site, Shreveport
Investigative Site, Little Rock
Investigative Site, Jonesboro
Investigative Site, Houston
Investigative Site, Denver
Investigative Site, Colorado Springs
Investigative Site, Boise
Investigative Site, Phoenix
Investigative Site, Phoenix
Investigative Site, Albuquerque
Investigative Site, Las Vegas
Investigative Site, Las Vegas
Investigative Site, San Diego
Investigative Site, San Diego
Investigative Site, Seattle
Investigative Site, Tacoma
Investigative Site, Moorestown
Lead Sponsor
Ferring Pharmaceuticals
INDUSTRY